Apple's Cook Heads ...
Health Care: Drugs
Regulus Therapeutics Inc (RGLS: NASDAQ)
$7.00 -0.10 | -1.41%
05/20/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | |||
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 40.55M | 9.18M | ||
| Receivables | 0.00 | 0.00 | ||
| Inventories | 0.00 | 0.00 | ||
| Other Current Assets | 0.00 | 0.00 | ||
| Total Current Assets | 98.93M | 38.67M | ||
| Property, Plant & Equipment, Gross | 5.75M | 4.61M | ||
| Accumulated Depreciation & Depletion | 2.44M | 1.50M | ||
| Property, Plant & Equipment, Net | 3.31M | 3.11M | ||
| Intangibles | 1.15M | 980.00K | ||
| Other Non-Current Assets | 125.00K | 125.00K | ||
| Total Non-Current Assets | 4.59M | 4.22M | ||
| Liabilities & Shareholder Equity | ||||
| Total Assets | 103.52M | 42.88M | ||
| Accounts Payable | 311.00K | 501.00K | ||
| Short Term Debt | 0.00 | 377.00K | ||
| Other Current Liabilities | 0.00 | 206.00K | ||
| Total Current Liabilities | 12.77M | 12.85M | ||
| Long Term Debt | 10.13M | 10.00M | ||
| Deferred Income Taxes | 0.00 | 446.00K | ||
| Other Non-Current Liabilities | 18.52M | 17.95M | ||
| Minority Interest | 0.00 | 0.00 | ||
| Total Non-Current Liabilities | 28.66M | 71.52M | ||
| Total Liabilities | 41.42M | 84.38M | ||
| Preferred Stock Equity | 0.00 | 0.00 | ||
| Common Stock Equity | 62.09M | -41.49M | ||
| Common Par | 36.00K | 0.00 | ||
| Additional Paid In Capital | 122.53M | 1.58M | ||
| Cumulative Translation Adjustment | 0.00 | 0.00 | ||
| Retained Earnings | -60.42M | -43.01M | ||
| Treasury Stock | 0.00 | 0.00 | ||
| Other Equity Adjustments | -52.00K | -67.00K | ||
| Total Capitalization | 72.23M | -31.49M | ||
| Total Equity | 62.09M | -41.49M | ||
| Total Liabilities & Stock Equity | 103.52M | 42.88M | ||
| Total Common Shares Outstanding | 35.83M | 34.13M | ||
| Preferred Shares | 0.00 | 0.00 | ||
| Treasury Shares | 0.00 | 0.00 | ||
| Basic Weighted Shares Outstanding | 8.21M | 15.18M | ||
| Diluted Weighted Shares Outstanding | 8.21M | 15.18M | ||
| Number of Employees | 66 | NA | ||
| Number of Part-Time Employees | 6 | NA | ||
Portfolios with RGLS
- Portfolio NameUser Type
Latest RGLS Headlines from TheStreet
- 8 Stocks Roaring Higher on Unusual Volume 12.27.12 | 03:12 pm
- Cramer's 'Mad Money' Recap: Focus on What Matters 10.15.12 | 07:10 pm
- IPOs: LifeLock, Luxfer, Regulus
10.02.12 | 06:10 am
Press Releases for RGLS
- Regulus Announces Timing For First Quarter 2013 Financial Results Webcast And Conference Call - PR Newswire 05.07.13 | 04:05 pm
- Regulus To Present At 12th Annual Needham Healthcare Conference - PR Newswire 04.24.13 | 04:04 pm
- Zosano Pharma, Inc. Expands Board Of Directors With Addition Of Kleanthis G. Xanthopoulos, Ph.D. - PR Newswire 04.15.13 | 11:04 am
- Regulus Appoints William H. Rastetter, Ph.D. To Its Board Of Directors - PR Newswire 04.01.13 | 08:04 am
- Regulus To Present At Future Leaders In The Biotech Industry Conference - PR Newswire 03.28.13 | 04:03 pm
- Regulus To Present At Cowen And Company 33rd Annual Healthcare Conference - PR Newswire 02.26.13 | 04:02 pm
- Regulus Announces Timing For Fourth Quarter And Year-End 2012 Financial Results Webcast And Conference Call - PR Newswire 02.13.13 | 04:02 pm
- Regulus To Present At Two Upcoming Investor Conferences - PR Newswire 02.04.13 | 04:02 pm
- Regulus Appoints Mark G. Foletta To Its Board Of Directors - PR Newswire 01.31.13 | 08:01 am
- Regulus To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 04:01 pm
Partner Headlines for RGLS
- UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress - Benzinga 11.29.12 | 01:11 pm
- Regulus Therapeutics: Serious Red Flags At This Public Offering - Seeking Alpha 10.08.12 | 09:10 am
- Six More IPOs this Week - NASDAQ 10.05.12 | 09:10 pm
